Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hair loss using 5% topical Minoxidil are satisfied with the treatment, but hair loss still affects their daily habits and social life.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Androgenetic alopecia in women needs more research and better management strategies.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

PRP injections increase hair density and diameter in female androgenetic alopecia patients.

Non-obese women with hair loss have higher heart disease risk.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

The document says that Androgenetic alopecia, a common hair loss condition, affects women less often and usually less severely, but early diagnosis and treatment are important.

Topical minoxidil improves life quality for women with hair loss.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Minoxidil use increases facial hair growth in females, more in older users.

Trichoscopy is a quick and reliable way to diagnose hair loss in women.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

Hair loss in men and women can be treated with medications and therapies, showing improvement after 6 months.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

The combined treatment improved scalp health in women with early-stage hair loss.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Low-level laser therapy helps male and female hair loss alone or with other treatments.

AR gene not major factor in female hair loss; different from male hair loss.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

There's no clear link between female pattern hair loss, insulin resistance, and metabolic syndrome.